ZBED5 can exert their influence via various cellular signaling pathways that ultimately lead to the functional activation of the protein. Forskolin is one such activator, which directly stimulates adenylate cyclase, thereby elevating intracellular cyclic AMP (cAMP) levels. The increase in cAMP can activate protein kinase A (PKA), which in turn can phosphorylate and activate ZBED5. Similarly, IBMX functions by inhibiting phosphodiesterases, which also leads to increased cAMP levels and subsequent PKA-mediated activation of ZBED5. Another activator, PMA, specifically activates protein kinase C (PKC), which is known to phosphorylate a broad range of target proteins, including ZBED5 within the PKC signaling pathway.
Adrenergic agonists such as Epinephrine and Isoproterenol also raise cAMP levels by binding to adrenergic receptors. This process activates PKA, which can phosphorylate and thereby activate ZBED5. Glucagon, by activating its specific GPCR, produces a similar effect through the cAMP/PKA signaling axis. Histamine, on the other hand, activates GPCR signaling pathways that lead to increased intracellular calcium, which can activate downstream kinases that may target ZBED5. Insulin activates the PI3K/AKT pathway, which can result in the activation of various proteins, potentially including ZBED5. Bradykinin, through its receptor, can elevate intracellular calcium and possibly lead to kinase activation that targets and activates ZBED5. The signaling molecule hydrogen peroxide can modulate tyrosine kinase activity, which may result in the oxidative activation of ZBED5. Nitric oxide donors release nitric oxide into cells, activating guanylate cyclase, which increases cGMP production and may influence kinases that activate ZBED5. Lastly, Lithium Chloride can inhibit GSK-3, leading to activation of the Wnt signaling pathway and subsequent modification and activation of ZBED5. Each of these chemicals, by targeting specific signaling molecules and pathways, can contribute to the activation state of ZBED5 in the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to increased cAMP levels, potentially enhancing PKA activity and subsequent activation of ZBED5. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and activate ZBED5 as part of the PKC signaling pathway. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can lead to increased intracellular cAMP and activation of PKA, potentially activating ZBED5. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, can increase cAMP levels, resulting in PKA activation and possible subsequent activation of ZBED5. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can activate GPCR signaling pathways that elevate intracellular calcium levels, potentially resulting in the activation of ZBED5. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/AKT pathway, which can lead to the phosphorylation and activation of various proteins, possibly including ZBED5. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates its GPCR to increase intracellular calcium levels, which can lead to the activation of downstream kinases and potentially ZBED5. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide can act as a signaling molecule that modulates tyrosine kinase activity, potentially leading to the oxidative activation of ZBED5. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, leading to Wnt pathway activation, which may lead to the modification and activation of various proteins including ZBED5. | ||||||